VulnerabilityModified
CVE-2023-27170
Xpand IT Write-back manager v2.3.1 allows attackers to perform a directory traversal via modification of the siteName parameter.
HIGH 7.5EPSS 0.79%
Does this matter?
High impact if exploited, but EPSS currently rates exploitation as unlikely (0.79%). Schedule it in the normal patch cycle and watch for a rise in EPSS or a public exploit.
Description
Xpand IT Write-back manager v2.3.1 allows attackers to perform a directory traversal via modification of the siteName parameter.
- CVSS 3.1
- 7.5 HIGHCVSS:3.1/AV:N/AC:H/PR:L/UI:N/S:U/C:H/I:H/A:H
- EPSS
- 0.79% probability · 54th percentile
- CISA KEV
- Not listed
- Weakness
- CWE-22
- Affected
- xpand-it/write-back manager
- Source
- cve@mitre.org
References
- https://balwurk.com/cve-2023-27170-improper-limitation-of-a-pathname-to-a-restricted-directory/Exploit, Third Party Advisory
- https://balwurk.com/cve-2023-27170-improper-limitation-of-a-pathname-to-a-restricted-directory/Exploit, Third Party Advisory
Source: NVD record, EPSS from FIRST.org, KEV from CISA. Refreshed daily.